AVBP ArriVent BioPharma, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
23:38
Aug 19
Aug 19
The author lists speculative biotech catalysts and best ideas by therapeutic area.
The author lists speculative biotech catalysts and best ideas by therapeutic area as research/watchlist content, not explicit current positions or forward calls.
23:36
Aug 19
Aug 19
Upcoming year-end binary data catalysts noted
Highlights upcoming year-end data catalysts for these biotech names, providing estimated upside and downside scenarios.
MED
11:28
Aug 17
Aug 17
A news wire reports a broad list of price target increases across dozens of stocks from various.
A news wire reports a broad list of price target increases across dozens of stocks from various analysts, with no directional commentary or personal market views expressed.
18:41
Jul 20
Jul 20
Short expecting Phase 3 failure; stock priced for success and vulnerable to large holder.
Short expecting Phase 3 failure; stock priced for success and vulnerable to large holder liquidation.
MED
About AVBP Analyst Coverage
Buzzberg tracks AVBP (ArriVent BioPharma, Inc.) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 4 total trade ideas tracked. Latest voices: seedy19tron, DeItaone.